SCT Annual Meeting Presentations & Videos
* Note that only Keynote Lectures and Trial of the Year are available to non-members for 2022 and 2023.
Members can login to view all presentations from recent years.
* Note that only Keynote Lectures and Trial of the Year are available to non-members for 2022 and 2023.
Members can login to view all presentations from recent years.
Discover SCT's Scientific Knowledge-Bank
300 Learning Opportunities Found
Arun J. Sanyal
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Curtis Meinert Lecture
The Future of Metabolic Medicine and Clinical Trials: A Patient-Centric Paradigm
The Future of Metabolic Medicine and Clinical Trials: A Patient-Centric Paradigm
Scott R. Evans
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Presidential Welcome
Shaping the Future: The Right Questions, Robust Answers
Shaping the Future: The Right Questions, Robust Answers
Sumit Gupta
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Trial of the Year Award
Blinatumomab and Childhood B-ALL: AALL1731, its Impact on Standard Treatment, and Unanswered Questions
Blinatumomab and Childhood B-ALL: AALL1731, its Impact on Standard Treatment, and Unanswered Questions
Scott R. Evans
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Special Presentation
Annual Business Meeting 2025
Annual Business Meeting 2025
David L. DeMets, PhD, Susan S. Ellenberg, PhD, Thomas R. Fleming, PhD, Frank W. Rockhold, PhD, ScM, Janet Wittes, PhD
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Founders Lecture
DMCs/DSMBs: Ongoing Challenges, Potential Solutions
DMCs/DSMBs: Ongoing Challenges, Potential Solutions
Katherine Guthrie
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Design Considerations for Multi-Cancer Detection Assay Clinical Trials: The NCI Cancer Screening Research Network
Design Considerations for Multi-Cancer Detection Assay Clinical Trials: The NCI Cancer Screening Research Network
Thomas Jensen
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Harnessing the Potential of Platform Trials in Chronic Diseases
Harnessing the Potential of Platform Trials in Chronic Diseases
Lai Wei
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Hierarchical composite endpoints and the Win Ratio: An approach to obtaining robust answers
Hierarchical composite endpoints and the Win Ratio: An approach to obtaining robust answers
Yuxi Zhao
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Enhancing Key Endpoint Evaluation and Monitoring with AI/ML and Risk-Based Strategies
Enhancing Key Endpoint Evaluation and Monitoring with AI/ML and Risk-Based Strategies
Marilly Palettas
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Advanced Novel Randomization Implementation in REDCap for Clinical Trials
Advanced Novel Randomization Implementation in REDCap for Clinical Trials
Kenichi Nakamura
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Overcoming Challenges in Rare Cancers: Leveraging Registry Data and Innovative Trial Designs
Overcoming Challenges in Rare Cancers: Leveraging Registry Data and Innovative Trial Designs
Therica Miller
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Shaping Equitable Access to Cancer Clinical Trials through AI and Navigation
Shaping Equitable Access to Cancer Clinical Trials through AI and Navigation
Yuliya Lokhnygina
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Issues in the Design of Studies with Hierarchical Endpoints
Issues in the Design of Studies with Hierarchical Endpoints
Stuart Nicholls
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Improving the clinical trial ecosystem to efficiently generate robust research and improve care
Improving the clinical trial ecosystem to efficiently generate robust research and improve care
Christopher Lindsell
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Establishing the University Data Coordinating Center (UNICORN) Network to Advance Data Coordination in Clinical Research
Establishing the University Data Coordinating Center (UNICORN) Network to Advance Data Coordination in Clinical Research
Barbara Wendelberger
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Stopping Progress: Finding Effective Treatments Using Disease Progression Modeling
Stopping Progress: Finding Effective Treatments Using Disease Progression Modeling
Charity Patterson
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Building an Evidence-Base for Exercise Medicine in Targeted Populations Through Rigorous Clinical Trials
Building an Evidence-Base for Exercise Medicine in Targeted Populations Through Rigorous Clinical Trials
Jessica Kasza
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Incomplete Variants of Stepped Wedge Cluster Randomized Designs: Recent Design Innovations and Considerations for Implementation
Incomplete Variants of Stepped Wedge Cluster Randomized Designs: Recent Design Innovations and Considerations for Implementation
Yuanye Zhang
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Pediatric Drug Development: Emerging Innovations and Future Directions
Pediatric Drug Development: Emerging Innovations and Future Directions
Edward Mascha
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Recent Advances in Addressing Design and Analysis Challenges of Cluster Randomized Trials
Recent Advances in Addressing Design and Analysis Challenges of Cluster Randomized Trials
Subodh Selukar
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
A Collaborative Approach for Developing Safety Stopping Rules in Phase 2 Oncology Clinical Trials
A Collaborative Approach for Developing Safety Stopping Rules in Phase 2 Oncology Clinical Trials
Brandon Bukas
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
A Collaborative Approach to Modernizing a Complex Data Viewing and Reporting System- Lessons Learned and Techniques Used
A Collaborative Approach to Modernizing a Complex Data Viewing and Reporting System- Lessons Learned and Techniques Used
Annie Wright
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
A Global Review of Decentralised Clinical Trials: Key Elements and Trends
A Global Review of Decentralised Clinical Trials: Key Elements and Trends
Peter Greenstreet
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
A multi-arm multi-stage design for trials with no control arm and all pairwise testing
A multi-arm multi-stage design for trials with no control arm and all pairwise testing
Alejandro Villasante-Tezanos
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
A non-parametric approach to predict recruitment for randomized clinical trials-Implementation in R
A non-parametric approach to predict recruitment for randomized clinical trials-Implementation in R
Chukwuemeka Emele
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
A practical solution to minimise selection and chronological bias in RCTs
A practical solution to minimise selection and chronological bias in RCTs
Guangyu Tong
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
A review of current practice in the design and analysis of extremely small stepped-wedge cluster randomized trials
A review of current practice in the design and analysis of extremely small stepped-wedge cluster randomized trials
Hyolim Lee
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
A review of primary outcome measures used in phase 2 Alzheimer’s trials
A review of primary outcome measures used in phase 2 Alzheimer’s trials
Stuart Nicholls
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
A scoping review of patient and public involvement in the design and conduct of cluster randomized trials conducted exclusively in low- and middle-income countries.
A scoping review of patient and public involvement in the design and conduct of cluster randomized trials conducted exclusively in low- and middle-income countries.
Shabnam Vatanpour
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
A Scoping Review of Response-adaptive Randomization Algorithms Used in Published Randomized Clinical Trials
A Scoping Review of Response-adaptive Randomization Algorithms Used in Published Randomized Clinical Trials
Quang Vuong
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
A Simulation Study on the Implications of Estimands in Treatment Switching in Meta-analyses
A Simulation Study on the Implications of Estimands in Treatment Switching in Meta-analyses
Caitlin Long
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
A Strategic Planning Checklist for Execution of Follow-Up in Clinical Trials for Critically Ill Children
A Strategic Planning Checklist for Execution of Follow-Up in Clinical Trials for Critically Ill Children
Andrew J Vickers Vickers
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
A systematic attempt to overcome barriers to accrual on randomized trials: lessons learned from 15 years of clinically-integrated trials at a major cancer center
A systematic attempt to overcome barriers to accrual on randomized trials: lessons learned from 15 years of clinically-integrated trials at a major cancer center
Ala Elhelali
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
A Systematic Review of Registered Clinical Trials for Peripheral Nerve Injuries
A Systematic Review of Registered Clinical Trials for Peripheral Nerve Injuries
Hayley Belli
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Educational Session
A tour of clinical trial designs: Demystifying which design to use for your study
A tour of clinical trial designs: Demystifying which design to use for your study
Mark Forrest
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Abstract: Advancing Trial Participant Engagement through a Tailored ePRO System
Abstract: Advancing Trial Participant Engagement through a Tailored ePRO System
Jennifer Kulesa-Kelley
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Accelerating Study Start-up in Two Multi-Site Intermediate-Size Expanded Access Protocols Through a Collaborative Approach of a Comprehensive Academic Research Organization
Accelerating Study Start-up in Two Multi-Site Intermediate-Size Expanded Access Protocols Through a Collaborative Approach of a Comprehensive Academic Research Organization
Shofiqul Islam
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Accounting for center-level effects in multicenter randomized controlled trials
Accounting for center-level effects in multicenter randomized controlled trials
Sangeetha Paramasivan
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Adapting the QuinteT Recruitment Intervention to Optimise Informed Consent in Clinical Trials in India: Lessons from the OrION-I Feasibility Study
Adapting the QuinteT Recruitment Intervention to Optimise Informed Consent in Clinical Trials in India: Lessons from the OrION-I Feasibility Study
Rafael Escandon
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Advanced Gene Therapy Research - More Small-Molecule or More-Transplant?
Advanced Gene Therapy Research - More Small-Molecule or More-Transplant?
Ian Rines
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Advanced Statistical Methodologies in Centralized Monitoring: Enhancing Efficiency and Data Integrity in Clinical Trials
Advanced Statistical Methodologies in Centralized Monitoring: Enhancing Efficiency and Data Integrity in Clinical Trials
Rajenki Das
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Advancements in Adaptive and Innovative Clinical Trial Design, Analysis, and Implementation by Early Career Researchers of MRC-NIHR Trial Methodology Research Partnership and Adaptive Design Working Group
Advancements in Adaptive and Innovative Clinical Trial Design, Analysis, and Implementation by Early Career Researchers of MRC-NIHR Trial Methodology Research Partnership and Adaptive Design Working Group
Francisco Diaz
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
An experimental design for clinical trials testing the individualization potential of an individualized treatment rule
An experimental design for clinical trials testing the individualization potential of an individualized treatment rule
Briha Ansari
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
An R Shiny Web Application for Data Monitoring and Quality Assurance in the Acute to Chronic Pain Signatures Study (A2CPS)
An R Shiny Web Application for Data Monitoring and Quality Assurance in the Acute to Chronic Pain Signatures Study (A2CPS)
Hannah Worboys
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Analysing health related quality of life in nephrology trials: A comparison of the linear mixed effects, standard joint, and competing risks joint models in the presence of informative dropouts.
Analysing health related quality of life in nephrology trials: A comparison of the linear mixed effects, standard joint, and competing risks joint models in the presence of informative dropouts.
Michael Rothe
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Analysis Using Intent-to-Treat Versus Per Protocol Reviews in Pragmatic Clinical Trials
Analysis Using Intent-to-Treat Versus Per Protocol Reviews in Pragmatic Clinical Trials
Emily Woolley
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Anticipated Actions Following the 2024 FDA Draft Guidance on Use of Data Monitoring Committees in Clinical Trials
Anticipated Actions Following the 2024 FDA Draft Guidance on Use of Data Monitoring Committees in Clinical Trials
Yuka SANO
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Application of the Flexible Parametric Cure Model to Clinical Trial Data – The Mean Survival Time as a Summary Measure of the Uncured Population.
Application of the Flexible Parametric Cure Model to Clinical Trial Data – The Mean Survival Time as a Summary Measure of the Uncured Population.
Laura Lovato
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Ascertained vs. Volunteered Events in Trials with Uneven Participant Contact (e.g., Lifestyle Interventions)
Ascertained vs. Volunteered Events in Trials with Uneven Participant Contact (e.g., Lifestyle Interventions)
Auden Krauska
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Assessing Adherence to CONSORT Reporting Guidelines Using AI
Assessing Adherence to CONSORT Reporting Guidelines Using AI
Christine Kohnen
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Assessing Free-text Fields through Natural Language Processing to Enhance CRF Development and Data Quality
Assessing Free-text Fields through Natural Language Processing to Enhance CRF Development and Data Quality
Theodore Karrison
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Assessing Treatment Benefit in Survival Analysis Under Nonproportional Hazards
Assessing Treatment Benefit in Survival Analysis Under Nonproportional Hazards
James Salsbury
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Assurance Methods for Designing a Survival Trial with Delayed Treatment Effects
Assurance Methods for Designing a Survival Trial with Delayed Treatment Effects
Jodi Gallant
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Attitudes of Patients and Caregivers to the Availability of a Dedicated Social Worker in the Outpatient Fracture Clinic
Attitudes of Patients and Caregivers to the Availability of a Dedicated Social Worker in the Outpatient Fracture Clinic
Donglin Yan
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Automated Monitoring and Alerts for Clinical Trial Operations
Automated Monitoring and Alerts for Clinical Trial Operations
Danila Azzolina
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Bayesian Dose-Response Analysis with Informative Priors on the Effect of Red Blood Cell Storage on Postoperative Infections
Bayesian Dose-Response Analysis with Informative Priors on the Effect of Red Blood Cell Storage on Postoperative Infections
Marianthie Wank
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Bayesian Estimation of Dynamic Treatment Regimes from a Partially Randomized, Patient Preference, Sequential, Multiple Assignment, Randomized Trial
Bayesian Estimation of Dynamic Treatment Regimes from a Partially Randomized, Patient Preference, Sequential, Multiple Assignment, Randomized Trial
Chin-Fu Hsiao
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Bayesian Hierarchical Mixture Models for Adaptive Basket Trial Design
Bayesian Hierarchical Mixture Models for Adaptive Basket Trial Design
Matthew Harris
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Bayesian In-Silico Clinical Trials Applied to Cancer Prevention: The importance of expert elicitation for key parameters in the absence of existing data using the SHELF method
Bayesian In-Silico Clinical Trials Applied to Cancer Prevention: The importance of expert elicitation for key parameters in the absence of existing data using the SHELF method
Matthew Harris
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Bayesian In-Silico Clinical Trials Applied to Obesity-related Cancer Prevention: The importance of expert elicitation for key parameters in the absence of existing data using the SHELF method
Bayesian In-Silico Clinical Trials Applied to Obesity-related Cancer Prevention: The importance of expert elicitation for key parameters in the absence of existing data using the SHELF method
Eric Leifer
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Bayesian vs. Frequentist Two-Armed Randomized Trial Monitoring Guidelines: Imaginary Prior Patients, Expected Sample Size, and Statistical Power
Bayesian vs. Frequentist Two-Armed Randomized Trial Monitoring Guidelines: Imaginary Prior Patients, Expected Sample Size, and Statistical Power
Fei Yuan
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Benchmarking subgroup health technology assessment analysis
Benchmarking subgroup health technology assessment analysis
Giles Partington
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Benefits and Risks of BOIN12 Design for Early Phase Oncology Trials under the Paradigm of Project Optimus
Benefits and Risks of BOIN12 Design for Early Phase Oncology Trials under the Paradigm of Project Optimus
Megan McCabe
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Benefits of Cross-Industry Training in Clinical Trials
Benefits of Cross-Industry Training in Clinical Trials
Tony Succar
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Best Practices for the Design and Conduct of Complex Clinical Trials
Best Practices for the Design and Conduct of Complex Clinical Trials
Xiaohan Chi
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
BOP2-Comb: Bayesian Optimal Phase II Design for Optimizing Doses and Assessing Contribution of Components in Drug Combinations
BOP2-Comb: Bayesian Optimal Phase II Design for Optimizing Doses and Assessing Contribution of Components in Drug Combinations
J Athene Lane
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Breathing Easy – Understanding the Success Of RAPID-TEST’s Clinical Trial Recruitment in Primary Care
Breathing Easy – Understanding the Success Of RAPID-TEST’s Clinical Trial Recruitment in Primary Care
Andrea Bastek
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Budgets Reimagined: Turbocharging Study Startup
Budgets Reimagined: Turbocharging Study Startup
Emily Alger
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Calibration of dose-agnostic priors for Bayesian dose-finding trial designs with joint outcomes
Calibration of dose-agnostic priors for Bayesian dose-finding trial designs with joint outcomes
Guosheng Yin
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Calibration-free odds CFO suite for designing various phase I clinical trials
Calibration-free odds CFO suite for designing various phase I clinical trials
Consuelo Nohpal de la Rosa
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Causal Inference Methods to Account for Compliance in Trials of Device Interventions
Causal Inference Methods to Account for Compliance in Trials of Device Interventions
Letitia Perdue
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Centralized Screening and Tracking in a Pragmatic Trial
Centralized Screening and Tracking in a Pragmatic Trial
Catherine Dillon
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Challenges and Solutions in CTMS Implementation for a Registry-based Platform Trial
Challenges and Solutions in CTMS Implementation for a Registry-based Platform Trial
Rouba Chahine
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Challenges Associated with Engaging External Sites in Clinical Research Conducted within pre-Established Networks: Experiences from the ACT NOW Weaning Trial.
Challenges Associated with Engaging External Sites in Clinical Research Conducted within pre-Established Networks: Experiences from the ACT NOW Weaning Trial.
Rebecca Sullenger
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Characteristics of Interventional Clinical Trials Started in 2023 Registered in ClinicalTrials.gov
Characteristics of Interventional Clinical Trials Started in 2023 Registered in ClinicalTrials.gov
Jodi Gallant
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Clinical Trial Transparency: Patient Preferences on Clinical Trial Results Dissemination Following the PREPARE Trial
Clinical Trial Transparency: Patient Preferences on Clinical Trial Results Dissemination Following the PREPARE Trial
Heidi Krause-Steinrauf
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Communicating Trial Results by Graphical Abstracts – Experiences from the GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Clinical Trial
Communicating Trial Results by Graphical Abstracts – Experiences from the GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Clinical Trial
NICK ZABOREK
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Complexities in Treatment-Emergent Adverse Event Analyses During Interim Monitoring
Complexities in Treatment-Emergent Adverse Event Analyses During Interim Monitoring
Sharon Love
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Educational Session
Conduct of Platform Trials
Conduct of Platform Trials
Abbey Staugaitis
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Consent Deviations in an Acute Ischemic Stroke Clinical Trial Utilizing Paper and Electronic Consent (eConsent)
Consent Deviations in an Acute Ischemic Stroke Clinical Trial Utilizing Paper and Electronic Consent (eConsent)
Kate Roberts
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Consent to access and use Health Systems Data for trials – Working Together with Patients and the Public to find appropriate language for participant-facing materials (CrossWord)
Consent to access and use Health Systems Data for trials – Working Together with Patients and the Public to find appropriate language for participant-facing materials (CrossWord)
Emily Bui
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Considerations for Medication Management in a Double-Blind, Randomized Placebo-Controlled Trial with an Unmatched Placebo
Considerations for Medication Management in a Double-Blind, Randomized Placebo-Controlled Trial with an Unmatched Placebo
SIYAO LI
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Covariate Adjustment Methods for Time-to-Event Outcomes in Randomized Trials: Accounting for Prognostic and Predictive Biomarkers
Covariate Adjustment Methods for Time-to-Event Outcomes in Randomized Trials: Accounting for Prognostic and Predictive Biomarkers
Dongquan Bi
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Current practice around the use of estimands in cluster randomised trials, and the impact of informative cluster size on inferences
Current practice around the use of estimands in cluster randomised trials, and the impact of informative cluster size on inferences
Danila Azzolina
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Defining Noninferiority Margins in Pediatric Critical Care Trials: A Bayesian Approach to Translating Risk Metrics for Clinical Relevance
Defining Noninferiority Margins in Pediatric Critical Care Trials: A Bayesian Approach to Translating Risk Metrics for Clinical Relevance
Sarah Medley
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Design and Analysis of SMARTs with Treatment Preference, with Application to the STAR*D Trial
Design and Analysis of SMARTs with Treatment Preference, with Application to the STAR*D Trial
Keith Pauls
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Design of an Electronic Delegation of Authority Log Within a Clinical Trial Management System
Design of an Electronic Delegation of Authority Log Within a Clinical Trial Management System
Kevin Venner
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Developing a Simple Plan for Implementation and Monitoring of Complex Randomization Algorithms
Developing a Simple Plan for Implementation and Monitoring of Complex Randomization Algorithms
Anna Catharina Vieira Armond
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Developing a standardized data management plan template for randomized controlled trials
Developing a standardized data management plan template for randomized controlled trials
Liam Bishop
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Developing Methods We Trust: A Workshop and Video Project with LICTR and the Culturally Diverse Hub
Developing Methods We Trust: A Workshop and Video Project with LICTR and the Culturally Diverse Hub
Welikanne Appuhamillage Ranga Pushpa Kumara
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Development of a Framework to Adopt Patient Centeredness within Electronic Health Record Systems in Sri Lanka
Development of a Framework to Adopt Patient Centeredness within Electronic Health Record Systems in Sri Lanka
Akash Roy
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Distance-Based Nonparametric Estimators for Comparing Groups in Behrens-Fisher Settings with Clustered Clinical Data
Distance-Based Nonparametric Estimators for Comparing Groups in Behrens-Fisher Settings with Clustered Clinical Data
Rebecca Metcalfe
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Diversity in Clinical Trials: How Actionable is Regulatory Guidance?
Diversity in Clinical Trials: How Actionable is Regulatory Guidance?
Liam Bishop
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Do Small Changes Lead to Big Improvements? Embedding EDI in a Value Driven Way in Clinical Trials Research Institute
Do Small Changes Lead to Big Improvements? Embedding EDI in a Value Driven Way in Clinical Trials Research Institute
Rebecca Silva
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Dose Individualization for Phase I Cancer Trials With Broadened Eligibility
Dose Individualization for Phase I Cancer Trials With Broadened Eligibility
Mollie Payne
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Dose Outcome using Stratified Estimation with Random Forest method (DOSE-RF): A novel approach to dose-response modelling in complex interventions.
Dose Outcome using Stratified Estimation with Random Forest method (DOSE-RF): A novel approach to dose-response modelling in complex interventions.
Mollie Payne
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Dose Outcome using Stratified Estimation with Random Forest method (DOSE-RF): A novel approach to non-linear dose-response modelling in complex interventions.
Dose Outcome using Stratified Estimation with Random Forest method (DOSE-RF): A novel approach to non-linear dose-response modelling in complex interventions.
Evan Bagley
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Dose-finding designs to account for patient heterogeneity in cancer clinical trials evaluating cell therapies.
Dose-finding designs to account for patient heterogeneity in cancer clinical trials evaluating cell therapies.
Shun-Fu Lee
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
DSMB Reflections: Key Takeaways from experience
DSMB Reflections: Key Takeaways from experience
Courtney Igne
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Dual Coordination Center Organization and Study Start-Up Operation Efficiencies for the ALL ALS Consortium
Dual Coordination Center Organization and Study Start-Up Operation Efficiencies for the ALL ALS Consortium
Gemma Ainsworth
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Early stage surgical trials: Shaping the future through improved statistical design and efficiency for robust decision making
Early stage surgical trials: Shaping the future through improved statistical design and efficiency for robust decision making
Audra Bright
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Effective Centralized Travel Management in a Multi-center Parkinson’s Disease Clinical Trial
Effective Centralized Travel Management in a Multi-center Parkinson’s Disease Clinical Trial
Ludovic Trinquart
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Empowering Patient-Centered Clinical Trial Design: A Novel Combination Test Framework
Empowering Patient-Centered Clinical Trial Design: A Novel Combination Test Framework
Brian Taylor
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Empowering Trial Teams: Developing Custom Tools for Operational Excellence in Clinical Trials
Empowering Trial Teams: Developing Custom Tools for Operational Excellence in Clinical Trials
Shivam Joshi
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Enhancing Covariate-Adaptive Randomization in a Clustered 2x2 Factorial Design Trial
Enhancing Covariate-Adaptive Randomization in a Clustered 2x2 Factorial Design Trial
Mirna Thomas
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Enhancing Data Quality in the HEALEY ALS Platform Trial through Systematic Outcome Review
Enhancing Data Quality in the HEALEY ALS Platform Trial through Systematic Outcome Review
Julissa Almonte
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Enhancing Efficiency and User Experience in the PREVENTABLE Study Drug System: Upgraded Features and Improved Operation
Enhancing Efficiency and User Experience in the PREVENTABLE Study Drug System: Upgraded Features and Improved Operation
Michelle Lancet
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Enhancing the Query Process in Clinical Trials Through the Use of a Query Portal System
Enhancing the Query Process in Clinical Trials Through the Use of a Query Portal System
Ashlyn Butkowski
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Enrollment and Operational Lessons Learned From the REFINE-ALS Study
Enrollment and Operational Lessons Learned From the REFINE-ALS Study
Yves Rosenberg
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Educational Session
Essentials of Clinical Trials
Essentials of Clinical Trials
Nikki Rousseau
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Educational Session
Essentials of process evaluation for clinical trials
Essentials of process evaluation for clinical trials
Rumana Omar
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Estimating and Interpreting Intervention Effects in Randomised Multi-session Therapy Trials with Partial Intervention Adherence – Is a Binary Definition of Compliance Appropriate?
Estimating and Interpreting Intervention Effects in Randomised Multi-session Therapy Trials with Partial Intervention Adherence – Is a Binary Definition of Compliance Appropriate?
Jacqueline Thompson
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
ESTIMATING RELATIVE RISKS AND RISK DIFFERENCES IN RANDOMISED CONTROLLED TRIALS: A SYSTEMATIC REVIEW OF CURRENT PRACTICE
ESTIMATING RELATIVE RISKS AND RISK DIFFERENCES IN RANDOMISED CONTROLLED TRIALS: A SYSTEMATIC REVIEW OF CURRENT PRACTICE
Morgaine Stiles
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Evaluating Estimand Implementation in Clinical Trials in the UK
Evaluating Estimand Implementation in Clinical Trials in the UK
Bryan Blette
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Evaluating Informative Cluster Size in Cluster-Randomized Trials
Evaluating Informative Cluster Size in Cluster-Randomized Trials
Mark Forrest
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Evaluating the Efficacy of Outbound IVR in Enhancing Follow-Up in a Multicentre Clinical Trial
Evaluating the Efficacy of Outbound IVR in Enhancing Follow-Up in a Multicentre Clinical Trial
Quentin Le Coent
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Evaluating the Use of Co-primary Endpoints in Trials Conducted Among Critically Ill Patients: Application for Delirium Trials
Evaluating the Use of Co-primary Endpoints in Trials Conducted Among Critically Ill Patients: Application for Delirium Trials
Yongdong Ouyang
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Exploring Bayesian Group-Sequential Designs in Multiple-Period Parallel-Arm Cluster Randomized Trials
Exploring Bayesian Group-Sequential Designs in Multiple-Period Parallel-Arm Cluster Randomized Trials
Kelsey Grantham
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Exploring incomplete stepped wedge designs: Balanced versus imbalanced staircase designs
Exploring incomplete stepped wedge designs: Balanced versus imbalanced staircase designs
Katherine Hull
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Exploring the adoption of thrice-weekly extended-hours in-centre nocturnal haemodialysis in routine clinical practice through the NightLife study: a qualitative content analysis
Exploring the adoption of thrice-weekly extended-hours in-centre nocturnal haemodialysis in routine clinical practice through the NightLife study: a qualitative content analysis
Carmel Conefrey
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Extending the reaches of recruitment research
Extending the reaches of recruitment research
Elham Sabri
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
External Challenges in Stepped Wedge cluster randomized trials: a case study of the prehospital Canadian C-spine Rule Trial
External Challenges in Stepped Wedge cluster randomized trials: a case study of the prehospital Canadian C-spine Rule Trial
Carmel Conefrey
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
From clinical trials to national evidence-informed guidelines to local commissioning policies to clinical practice: an examination of commissioners’ responses to national evidence-informed guidelines for the de-implementation of surgical procedures
From clinical trials to national evidence-informed guidelines to local commissioning policies to clinical practice: an examination of commissioners’ responses to national evidence-informed guidelines for the de-implementation of surgical procedures
Yuhan Qian
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
From Estimands to Robust Inference of Treatment Effect in Platform Trials
From Estimands to Robust Inference of Treatment Effect in Platform Trials
Xinying Fang
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
G-BOP2: Generalized Bayesian Optimal Phase II Designs with Particle Swarm Optimization
G-BOP2: Generalized Bayesian Optimal Phase II Designs with Particle Swarm Optimization
Wendimagegn Alemayehu
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Geographical variation in multinational phase III clinical trials
Geographical variation in multinational phase III clinical trials
Emily O'Brien
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Educational Session
Getting Robust Answers to Meaningful Questions: Essentials of Embedded Pragmatic Clinical Trials Workshop
Getting Robust Answers to Meaningful Questions: Essentials of Embedded Pragmatic Clinical Trials Workshop
Edward Mills
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Global Health Solutions: Scaling Clinical Trial Human Resources in Low- and Middle-Income Countries
Global Health Solutions: Scaling Clinical Trial Human Resources in Low- and Middle-Income Countries
Katrina Dobinda
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Graphical Representation of Adverse Events in Clinical Trials
Graphical Representation of Adverse Events in Clinical Trials
Sharon Love
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Greener Academic Clinical Trial Monitoring
Greener Academic Clinical Trial Monitoring
Baptiste Leurent
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Handling of Incomplete Baseline Covariates in Cluster-Randomised Trials: A Simulation Study
Handling of Incomplete Baseline Covariates in Cluster-Randomised Trials: A Simulation Study
Chris Cook
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Harnessing Artificial intelligence in Data Management
Harnessing Artificial intelligence in Data Management
Nicola Mills
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Educational Session
How can we rapidly improve recruitment to clinical trials in ‘real time’? Sharing methods and techniques for delivering the ‘QuinteT Recruitment Intervention’ to support recruitment to challenging trials
How can we rapidly improve recruitment to clinical trials in ‘real time’? Sharing methods and techniques for delivering the ‘QuinteT Recruitment Intervention’ to support recruitment to challenging trials
Sadia Ahmed
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
How does the use of a video to introduce a complex intervention affect service user uptake and engagement? Results from a mixed-methods SWAT
How does the use of a video to introduce a complex intervention affect service user uptake and engagement? Results from a mixed-methods SWAT
Kara-Louise Royle
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
How to account for subsequent anti-cancer therapy when analysing overall survival: A simulation study and practical example
How to account for subsequent anti-cancer therapy when analysing overall survival: A simulation study and practical example
Melissa Crane
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Human-Centered Design Studios for Advancing Inclusive Recruitment and Retention in Clinical Trials: Audience Perceptions of Utility
Human-Centered Design Studios for Advancing Inclusive Recruitment and Retention in Clinical Trials: Audience Perceptions of Utility
Valerie Stevenson
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Identifying and Mitigating Barriers in the Initiation of Clinical Trials
Identifying and Mitigating Barriers in the Initiation of Clinical Trials
Valerie Stevenson
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Identifying and Mitigating the Impact of Clinical Research Professional Attrition In Clinical Trials
Identifying and Mitigating the Impact of Clinical Research Professional Attrition In Clinical Trials
Cory Goldstein
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Identifying gaps in ethics guidelines for cluster randomized trials: a citation analysis
Identifying gaps in ethics guidelines for cluster randomized trials: a citation analysis
Nancy Leung
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Identifying immune biomarkers other than neutralising antibodies as correlate of protection for COVID-19 vaccines
Identifying immune biomarkers other than neutralising antibodies as correlate of protection for COVID-19 vaccines
Scott Evans
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Impact of Recent US Government Actions: A Late-breaking Panel with Audience Discussion
Impact of Recent US Government Actions: A Late-breaking Panel with Audience Discussion
Charis Xie
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Impact of Using Routine Data on the Efficiency of Implementation Trials: A Qualitative Comparative Case Study
Impact of Using Routine Data on the Efficiency of Implementation Trials: A Qualitative Comparative Case Study
Jean-Christophe Arnaud
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Implementation Strategy for Incorporating Registration Data into Clinical Trial Case Report Forms
Implementation Strategy for Incorporating Registration Data into Clinical Trial Case Report Forms
Marissa Dulas
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Improving Data Collection Efficiency: Integration of Internal Hospital Databases with REDCap
Improving Data Collection Efficiency: Integration of Internal Hospital Databases with REDCap
Arishay Hussaini
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Improving Informed Consent for Critical Care Trials in Pakistan
Improving Informed Consent for Critical Care Trials in Pakistan
Nick Bansback
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Incorporating the Patient Voice into Clinical Trial Design to Increase Enrolment
Incorporating the Patient Voice into Clinical Trial Design to Increase Enrolment
S Cowtan
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Incorporating Variation in Biomarker Prevalence in Statistical Predictive Models of Trial Recruitment for Multi-Centre trials
Incorporating Variation in Biomarker Prevalence in Statistical Predictive Models of Trial Recruitment for Multi-Centre trials
Mitra Lewis
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Increasing Efficiency: Standardization of an Inventory Management Process in Multisite Clinical Trials
Increasing Efficiency: Standardization of an Inventory Management Process in Multisite Clinical Trials
J Athene Lane
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Integrated Participant Digital Storytelling (IPDS): an Innovative Method for Disseminating Participant Experiences for Clinical Trials and Training
Integrated Participant Digital Storytelling (IPDS): an Innovative Method for Disseminating Participant Experiences for Clinical Trials and Training
Jacklyn Harris
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Integrating Clinical Trial Manual of Procedures and Data System Development: A Refined Process Approach
Integrating Clinical Trial Manual of Procedures and Data System Development: A Refined Process Approach
Brittney Harkey
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Integrating Interim Analyses and DSMB Oversight in Adaptive Platform Trials: Operational Infrastructure of the HEALEY ALS Platform Trial
Integrating Interim Analyses and DSMB Oversight in Adaptive Platform Trials: Operational Infrastructure of the HEALEY ALS Platform Trial
Wenle Zhao
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Integrating IRT into EDC for Advanced Randomization Designs
Integrating IRT into EDC for Advanced Randomization Designs
Danila Azzolina
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Integrating Synthetic Data and AI in Pediatric Intensive Care Clinical Trials: A Bayesian Framework for Ethical and Scientific Advancement
Integrating Synthetic Data and AI in Pediatric Intensive Care Clinical Trials: A Bayesian Framework for Ethical and Scientific Advancement
Roberta Bruhn
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Integration of AI in Epidemiological Study Design for Enhanced Research Outcomes
Integration of AI in Epidemiological Study Design for Enhanced Research Outcomes
Yan Liu
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Intention-To-Treat Analysis: A Systematic Review on Recommendations and How to Use It Appropriately
Intention-To-Treat Analysis: A Systematic Review on Recommendations and How to Use It Appropriately
Jibin Li
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Investigation about the perceptions of clinical investigators towards barriers to the appropriate use of non-inferiority design in oncological trials
Investigation about the perceptions of clinical investigators towards barriers to the appropriate use of non-inferiority design in oncological trials
Jodi Gallant
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Job Satisfaction of Research Personnel in Orthopaedic Trauma Surgery
Job Satisfaction of Research Personnel in Orthopaedic Trauma Surgery
Bryce Wiley
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Latent Transition Analysis to Identify Patterns in Atherosclerotic Risk Factor Data Across Time
Latent Transition Analysis to Identify Patterns in Atherosclerotic Risk Factor Data Across Time
Shelby Roberts
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Leading Platform Trials with the Precision of a Basketball Coach: Strategies for Success
Leading Platform Trials with the Precision of a Basketball Coach: Strategies for Success
Anju Joseph
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Leveraging Artificial Neural Networks for Enhanced Heart Disease Prediction.
Leveraging Artificial Neural Networks for Enhanced Heart Disease Prediction.
Seung Ho (Charlie) Choi
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Leveraging Interactive Data Visualization Software to Enhance Data Reporting and Quality: Examples from a Multi-Center Clinical Trial
Leveraging Interactive Data Visualization Software to Enhance Data Reporting and Quality: Examples from a Multi-Center Clinical Trial
Jonathan Beall
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Leveraging seasonal variation for predicting accrual in clinical trials using Bayesian posterior predictive distributions
Leveraging seasonal variation for predicting accrual in clinical trials using Bayesian posterior predictive distributions
Scott Rushing
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Management of Biospecimens in the MoTrPAC Study – DMAQC Perspective
Management of Biospecimens in the MoTrPAC Study – DMAQC Perspective
Khalif Halani
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Managing Information Overrun and Underrun in Clinical Trials with Interim Analyses
Managing Information Overrun and Underrun in Clinical Trials with Interim Analyses
Marci Livingston
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Mapping Methodological Guidance for Including Lived Experience in Early Core Outcome Set Development: A Scoping Review
Mapping Methodological Guidance for Including Lived Experience in Early Core Outcome Set Development: A Scoping Review
Hannah Worboys
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Mapping the KDQoL-36 onto the EQ-5D-5L Utility Index in Patients undergoing Haemodialysis
Mapping the KDQoL-36 onto the EQ-5D-5L Utility Index in Patients undergoing Haemodialysis
Anh Phan
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Measuring the Success of Treatment Blinding in Sham-Controlled Trials
Measuring the Success of Treatment Blinding in Sham-Controlled Trials
Sabine Dreibe
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Methodological Features of Early Phase Non-Randomised Adaptive Platform Trials: A Comprehensive Review of Design, Implementation and Reporting
Methodological Features of Early Phase Non-Randomised Adaptive Platform Trials: A Comprehensive Review of Design, Implementation and Reporting
Timothy Leonard
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Methods and Considerations for the Recruitment of an International Patient Population for the Rare Disease GNE Myopathy
Methods and Considerations for the Recruitment of an International Patient Population for the Rare Disease GNE Myopathy
Kousick Biswas
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Mid-study Implementation of a Virtual Hub-and-Spoke RCT in the VA
Mid-study Implementation of a Virtual Hub-and-Spoke RCT in the VA
Gibbi Sey
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Monitoring a cluster-randomized trial on Mass R21 malaria vaccination in The Gambia and Burkina Faso: Key findings and resolution strategies
Monitoring a cluster-randomized trial on Mass R21 malaria vaccination in The Gambia and Burkina Faso: Key findings and resolution strategies
Veronica Tonwe
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Moving from Evidence to Framework: The Development of an Implementation Science Trial Oversight Framework (IS-TOF) to Guide Clinical Trial Monitoring.
Moving from Evidence to Framework: The Development of an Implementation Science Trial Oversight Framework (IS-TOF) to Guide Clinical Trial Monitoring.
Chris Rogers
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Multiplicity considerations in the design and analysis of a non-licensing randomised controlled trial evaluating three treatments with two primary outcomes
Multiplicity considerations in the design and analysis of a non-licensing randomised controlled trial evaluating three treatments with two primary outcomes
Katie Pike
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Multiplicity in non-licensing randomized controlled trials: software tool to calculate sample sizes
Multiplicity in non-licensing randomized controlled trials: software tool to calculate sample sizes
Katie Pike
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Multiplicity in non-licensing randomized controlled trials: when and how to adjust
Multiplicity in non-licensing randomized controlled trials: when and how to adjust
Finbar Slevin
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Must-Haves or Nice-to-Haves: Community Outreach to Inform Research Inclusion in Funding Applications: Case Studies from the Leeds Institute of Clinical Trials Research Research - Three Case Studies from LICTR
Must-Haves or Nice-to-Haves: Community Outreach to Inform Research Inclusion in Funding Applications: Case Studies from the Leeds Institute of Clinical Trials Research Research - Three Case Studies from LICTR
Evan Tomaschek
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Navigating Safety Reporting in a Rare Disease Setting
Navigating Safety Reporting in a Rare Disease Setting
Michael Moshinsky
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
NeuroNEXT Consortium - Network Renewal and Pre-Award Proposal Process Updates
NeuroNEXT Consortium - Network Renewal and Pre-Award Proposal Process Updates
Iris Davis
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
NIH StrokeNet International Trials Implementation
NIH StrokeNet International Trials Implementation
Joan Ohayon
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
NINDS Offers Innovative Approach for Funding Clinical Trials in Adult and Pediatric Populations using Other Transactions Authority
NINDS Offers Innovative Approach for Funding Clinical Trials in Adult and Pediatric Populations using Other Transactions Authority
Amber Boose
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
No Patient Diaries Allowed: Building a Pragmatic Dose Optimization Study in REDCap
No Patient Diaries Allowed: Building a Pragmatic Dose Optimization Study in REDCap
Brian Egleston
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Non-Inferiority and Equivalency Testing in the Four Arm Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eReach2).
Non-Inferiority and Equivalency Testing in the Four Arm Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eReach2).
Gustavo Jimenez-Maggiora
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Open Science: Sharing Data and Resources in Alzheimer’s Disease Clinical Trials
Open Science: Sharing Data and Resources in Alzheimer’s Disease Clinical Trials
Juliet High
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Opportunities for Trial Management Staff to Add Further Value to Clinical Trials and Enhance Their Own Career Development: Some Case Studies
Opportunities for Trial Management Staff to Add Further Value to Clinical Trials and Enhance Their Own Career Development: Some Case Studies
Samuel Sarkodie
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Optimal drop-the-loser trials when an intermediate endpoint is used for interim selection
Optimal drop-the-loser trials when an intermediate endpoint is used for interim selection
Xiaohan Mei
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Optimal Power Analysis For Testing Hierarchical Endpoints in a Group Sequential Design
Optimal Power Analysis For Testing Hierarchical Endpoints in a Group Sequential Design
Vilma Okey-Ewurum
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Optimizing Data Entry and Enhancing Protocol Adherence through Dynamic Electronic Form Visibility in a Multi-Site Clinical Study
Optimizing Data Entry and Enhancing Protocol Adherence through Dynamic Electronic Form Visibility in a Multi-Site Clinical Study
Christine Kohnen
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Optimizing Data Quality using Interactive Visualizations for Data Cleaning and Query Resolution
Optimizing Data Quality using Interactive Visualizations for Data Cleaning and Query Resolution
Hannah Palac
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Optimizing Database Search Strategies to Identify Increased Cardiovascular Risk Patients in Clinical Trials
Optimizing Database Search Strategies to Identify Increased Cardiovascular Risk Patients in Clinical Trials
Saira Anam Qadir
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Optimizing External Vendor Data Management Process
Optimizing External Vendor Data Management Process
Danila Azzolina
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Optimizing Pediatric Outcomes: Advanced Bayesian Modeling of Days Without Mechanical Ventilation in Intensive Care Trials
Optimizing Pediatric Outcomes: Advanced Bayesian Modeling of Days Without Mechanical Ventilation in Intensive Care Trials
Lia Tamburello
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Optimizing Trial Success: Key Staffing Considerations for Platform Trials
Optimizing Trial Success: Key Staffing Considerations for Platform Trials
Scott Rushing
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Overcoming Communication and Project Management Challenges in Developing Data Management Tools for Clinical Research Using Clickup Project Management Software
Overcoming Communication and Project Management Challenges in Developing Data Management Tools for Clinical Research Using Clickup Project Management Software
Ajsi Kanapari
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Paired Matched randomization: the effect of incorporating Real World Data and Machine Learning Methods in Clinical trials
Paired Matched randomization: the effect of incorporating Real World Data and Machine Learning Methods in Clinical trials
Daniel Daly-Grafstein
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Partial identification for discrete data with nonignorable missing outcomes
Partial identification for discrete data with nonignorable missing outcomes
Debby Oladimeji
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Participant Diversity and Inclusive Trial Design: A Meta-Epidemiologic Study of Canadian Randomized Clinical Trials
Participant Diversity and Inclusive Trial Design: A Meta-Epidemiologic Study of Canadian Randomized Clinical Trials
Nikki Totton
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Patient and Public Involvement and Engagement to Methodological Research: Insights from a Panel
Patient and Public Involvement and Engagement to Methodological Research: Insights from a Panel
Motahareh Karimijashni
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Patient and public involvement in Canadian randomized controlled trials: A scoping review
Patient and public involvement in Canadian randomized controlled trials: A scoping review
Tolulope Sajobi
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Perceptions and Satisfaction with Work-Life Balance and Wellness of Collaborative Statisticians & Methodologists in Multidisciplinary and Clinical Trials Settings
Perceptions and Satisfaction with Work-Life Balance and Wellness of Collaborative Statisticians & Methodologists in Multidisciplinary and Clinical Trials Settings
Joyce Samuel
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Personalizing hypertension treatment using n-of-1 trials
Personalizing hypertension treatment using n-of-1 trials
Emily Woolley
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Educational Session
Pillars for Effective Data Monitoring Committees (DMCs): Current regulatory considerations, proactive Charters, tailored summaries, and alternative operational support models
Pillars for Effective Data Monitoring Committees (DMCs): Current regulatory considerations, proactive Charters, tailored summaries, and alternative operational support models
Courtney Simmons
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Pilot Study of a Tool to Personalize the Cardiopulmonary Exercise Test in MoTrPAC
Pilot Study of a Tool to Personalize the Cardiopulmonary Exercise Test in MoTrPAC
Ryan Berry
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Pioneering Physician-Led Trials: Transforming Treatment for Adrenal Insufficiency and Beyond
Pioneering Physician-Led Trials: Transforming Treatment for Adrenal Insufficiency and Beyond
Amy Crawford
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Planning for Heterogeneous Treatment Effects: Enrichment for Treatment-Sensitive Patient Populations
Planning for Heterogeneous Treatment Effects: Enrichment for Treatment-Sensitive Patient Populations
Lee Ding
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Power calculation for group sequential cluster randomized trials with continuous or binary outcomes
Power calculation for group sequential cluster randomized trials with continuous or binary outcomes
Shrikant Bangdiwala
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Pragmatic monitoring of emerging efficacy data in randomized controlled trials
Pragmatic monitoring of emerging efficacy data in randomized controlled trials
Jialu Fang
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Precision CFO: A refined calibration-free odds design with interface-based software for phase I clinical trials
Precision CFO: A refined calibration-free odds design with interface-based software for phase I clinical trials
Jonathan Beall
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Precision Unlocked: Adaptive Sample Size Re-Estimation for Interim Insights
Precision Unlocked: Adaptive Sample Size Re-Estimation for Interim Insights
Rishi Bansal
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Preliminary results from a systematic review of Bayesian methodological approaches used in the design and analysis of contemporary randomized clinical trials
Preliminary results from a systematic review of Bayesian methodological approaches used in the design and analysis of contemporary randomized clinical trials
Jodi Gallant
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Prevalence and Acceptability of Dedicated Social Work Support in the Fracture Clinic: A Survey of Orthopaedic Trauma Surgeons
Prevalence and Acceptability of Dedicated Social Work Support in the Fracture Clinic: A Survey of Orthopaedic Trauma Surgeons
Yongdong Ouyang
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Prior Distributions from Envisioned Posterior Judgments: A Novel Elicitation Approach With Application to Bayesian Clinical Trials
Prior Distributions from Envisioned Posterior Judgments: A Novel Elicitation Approach With Application to Bayesian Clinical Trials
Emily Alger
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
PRO-ADD: Patient-Empowered Dose-Finding Trials by Integrating Safety, Efficacy and Patient-Reported Outcomes for Optimal Dose Selection
PRO-ADD: Patient-Empowered Dose-Finding Trials by Integrating Safety, Efficacy and Patient-Reported Outcomes for Optimal Dose Selection
Matt Hammond
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Promoting Accessibility in Clinical Trials (PRACTICALs): Development and pilot testing of an eLearning resource
Promoting Accessibility in Clinical Trials (PRACTICALs): Development and pilot testing of an eLearning resource
Kai Wang
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
PS-integrated Bayesian proactive dynamic borrowing strategy based on the quantitative evaluation of exchangeability of the hybrid control arm.
PS-integrated Bayesian proactive dynamic borrowing strategy based on the quantitative evaluation of exchangeability of the hybrid control arm.
Maeve Coyle
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Qualitative methods to optimise complex intervention delivery in trials: A case study
Qualitative methods to optimise complex intervention delivery in trials: A case study
JiBin Li
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Quality Assessment of Non-inferiority Trials in Oncology based on CONSORT Guideline
Quality Assessment of Non-inferiority Trials in Oncology based on CONSORT Guideline
Lauren Edgar
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Racial Minority Participation in Decentralized Clinical Trials for Rare Genetic Diseases
Racial Minority Participation in Decentralized Clinical Trials for Rare Genetic Diseases
Lukas Pin
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Randomization-based Inference for MCP-Mod
Randomization-based Inference for MCP-Mod
Lukas Pin
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Randomization-based Inference for MCP-Mod
Randomization-based Inference for MCP-Mod
Michael Otterstatter
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Rates and Predictors of Missingness in Clinical Trials for Substance Use: A Secondary Analysis of Eight NIDA Clinical Trials Network Studies
Rates and Predictors of Missingness in Clinical Trials for Substance Use: A Secondary Analysis of Eight NIDA Clinical Trials Network Studies
Leila Rooshenas
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Re-thinking the challenges of recruiting to clinical trials: evidence-based insights from the Quintet Recruitment Intervention (QRI)
Re-thinking the challenges of recruiting to clinical trials: evidence-based insights from the Quintet Recruitment Intervention (QRI)
Jodi Gallant
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Reasons for Declining to Participate in a Trial of Online Cognitive Behavioural Therapy Following Orthopaedic Trauma: A Mixed Methods Study
Reasons for Declining to Participate in a Trial of Online Cognitive Behavioural Therapy Following Orthopaedic Trauma: A Mixed Methods Study
Stuart Nicholls
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Recognition, remuneration and reimbursement of patient and public research partners in pragmatic randomised controlled trials. A survey of author practices.
Recognition, remuneration and reimbursement of patient and public research partners in pragmatic randomised controlled trials. A survey of author practices.
Brianna Conley
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Recruitment Strategies and Impact in a Cancer Clinical Trial
Recruitment Strategies and Impact in a Cancer Clinical Trial
Richard Zink
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Recurrence: Considering the Timing and Reappearance of Adverse Events for Greater Insight into Patient Safety
Recurrence: Considering the Timing and Reappearance of Adverse Events for Greater Insight into Patient Safety
Ban Majeed
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Reduction in Tobacco Use as Unintended Positive Outcome Among Zambian Young Adults Who Completed Hopes for Life Communities, a Character Strength-Based Curriculum: A Secondary Data Analysis of a Randomized Clinical Trial.
Reduction in Tobacco Use as Unintended Positive Outcome Among Zambian Young Adults Who Completed Hopes for Life Communities, a Character Strength-Based Curriculum: A Secondary Data Analysis of a Randomized Clinical Trial.
Qihang Wu
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Refining Data Presentation in Data and Safety Monitoring Boards Reports: An Example from a Clinical Trial Evaluating Antifungal Therapy in Pediatric Uncomplicated Candidemia
Refining Data Presentation in Data and Safety Monitoring Boards Reports: An Example from a Clinical Trial Evaluating Antifungal Therapy in Pediatric Uncomplicated Candidemia
Arlene Jiang
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Remote, bivariate expert elicitation to determine the prior probability distribution for a Bayesian non-inferiority multicenter randomized controlled trial
Remote, bivariate expert elicitation to determine the prior probability distribution for a Bayesian non-inferiority multicenter randomized controlled trial
Alexandra Gil
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
REMOTE, CENTRALIZED MONITORING OF THE INFORMED CONSENT PROCESS IN MULTICENTER TRIALS.
REMOTE, CENTRALIZED MONITORING OF THE INFORMED CONSENT PROCESS IN MULTICENTER TRIALS.
Jessica Kasza
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Repeated inclusion of clusters in longitudinal cluster randomised trials
Repeated inclusion of clusters in longitudinal cluster randomised trials
Georgiana Synesi
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
REPRESENT: Exploring barriers to recruitment of underrepresented groups in bladder and head & neck oncology trials
REPRESENT: Exploring barriers to recruitment of underrepresented groups in bladder and head & neck oncology trials
Claudia Grossmann
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Research Done Differently®: Tools for rigorous and efficient patient-centered trials
Research Done Differently®: Tools for rigorous and efficient patient-centered trials
Maria Vittoria Chiaruttini
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Response Adaptive Randomization Based On Activity Digital Outcomes In Cancer Trials
Response Adaptive Randomization Based On Activity Digital Outcomes In Cancer Trials
Megan O'Sullivan
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Results may vary: Using simulation methods to improve diversity in clinical trials
Results may vary: Using simulation methods to improve diversity in clinical trials
Corinne Gant
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Revisiting Futility Monitoring in Clinical Trials
Revisiting Futility Monitoring in Clinical Trials
Yunhe Liu
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Robust dynamic borrowing designs for randomized basket trials: a case study from the ultra-rare invasive mould infections
Robust dynamic borrowing designs for randomized basket trials: a case study from the ultra-rare invasive mould infections
Marlena Bannick
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Robust estimation and inference following the use of covariates at the design and analysis stages of a clinical trial
Robust estimation and inference following the use of covariates at the design and analysis stages of a clinical trial
Gillian Gresham
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Role of wearable technology in clinical trials: A single institution experience
Role of wearable technology in clinical trials: A single institution experience
Ruitao Lin
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Sample Size Determination for Decentralized Clinical Trials
Sample Size Determination for Decentralized Clinical Trials
Callum Vyner
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Sample Size in Crossed-Design Surgical Trials: are we ignoring the non-ignorable? Exploring the effects of treatment heterogeneity, recruitment rates, and different operating-characteristics on sample size
Sample Size in Crossed-Design Surgical Trials: are we ignoring the non-ignorable? Exploring the effects of treatment heterogeneity, recruitment rates, and different operating-characteristics on sample size
TAKUMI KANATA
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Sample Size Re-Estimation for Non-Randomized Prospective Trials using Propensity Score Weighting
Sample Size Re-Estimation for Non-Randomized Prospective Trials using Propensity Score Weighting
Sasha Amdur Kravets
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Sample size re-estimation in cluster randomized clinical trials
Sample size re-estimation in cluster randomized clinical trials
Chloé Szurewsky
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Score tests for non-proportional hazards in single-arm clinical trials with time-to-event endpoints: a simulation study
Score tests for non-proportional hazards in single-arm clinical trials with time-to-event endpoints: a simulation study
Viktor Osadsky
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Scoring Radiography Collimation: Quantifying Background Impact Using Neural Networks
Scoring Radiography Collimation: Quantifying Background Impact Using Neural Networks
Anna Gudjonsdottir
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Sharing Clinical Trial Data in Limited-Access Repositories: An Example from NeuroNEXT
Sharing Clinical Trial Data in Limited-Access Repositories: An Example from NeuroNEXT
Gloria Brigiari
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Simulation-Based External Validation of Survival Models for Risk Stratification in Oncology
Simulation-Based External Validation of Survival Models for Risk Stratification in Oncology
Quang Vuong
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Simulation-Guided Trial Planning for Different Estimands for Treatment Switching in Oncology
Simulation-Guided Trial Planning for Different Estimands for Treatment Switching in Oncology
Timofei Biziaev
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Site-Specific Covariate and Group Size Imbalance in Multicenter Acute Stroke Trials: A Comparison of Covariate-Adaptive Randomization and Block Randomization Strategies
Site-Specific Covariate and Group Size Imbalance in Multicenter Acute Stroke Trials: A Comparison of Covariate-Adaptive Randomization and Block Randomization Strategies
Pavel Roshanov
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Site-variable allocation ratios in randomized controlled trials: implications for sample size, recruitment efficiency, and statistical analysis
Site-variable allocation ratios in randomized controlled trials: implications for sample size, recruitment efficiency, and statistical analysis
Clare Relton
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Staged Informed Consent for Trials with Usual Care Groups: Developing Guidance
Staged Informed Consent for Trials with Usual Care Groups: Developing Guidance
Lu Mao
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Statistical methods for complex survival and longitudinal outcomes in clinical trials
Statistical methods for complex survival and longitudinal outcomes in clinical trials
Leah Welty
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
StatWrap: A Software Tool for Managing Variation and Change in Support of Reproducible and Robust Research
StatWrap: A Software Tool for Managing Variation and Change in Support of Reproducible and Robust Research
Rick Garvey
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Strategies for Increasing Clinical Trial Follow-up Among Recently Discharged, Low-income Hospital Patients with Opioid Use Disorder
Strategies for Increasing Clinical Trial Follow-up Among Recently Discharged, Low-income Hospital Patients with Opioid Use Disorder
Adwoa Parker
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Strategies to improve recruitment to randomised trials: Cochrane systematic review
Strategies to improve recruitment to randomised trials: Cochrane systematic review
Alison Huang
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Strategies, Obstacles, and Facilitators for Remote Trials Administering Physical Activity-Based Interventions and Performing Physical Function Assessments: the Lessening Incontinence with Low-impact Activity Trial
Strategies, Obstacles, and Facilitators for Remote Trials Administering Physical Activity-Based Interventions and Performing Physical Function Assessments: the Lessening Incontinence with Low-impact Activity Trial
Tara Beckner
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Streamlining PROMIS Scoring by Using an Application Programming Interface (API) for Automation in the Look AHEAD Aging Study
Streamlining PROMIS Scoring by Using an Application Programming Interface (API) for Automation in the Look AHEAD Aging Study
Lara Philipps
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Study within a trial of electronic versus paper-based Patient Reported oUtcomes CollEction (SPRUCE) - primary outcome and patient demographics
Study within a trial of electronic versus paper-based Patient Reported oUtcomes CollEction (SPRUCE) - primary outcome and patient demographics
Chia-Rui Chang
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Subgroup Identification for Cluster Randomized Trials
Subgroup Identification for Cluster Randomized Trials
Wenle Zhao
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Subject Randomization for Bayesian Adaptive Trials with Multi-arm Unequal Allocations
Subject Randomization for Bayesian Adaptive Trials with Multi-arm Unequal Allocations
Sarah Gaussoin
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Summarizing Data from Multiple Sources for Use in Cognitive Adjudication
Summarizing Data from Multiple Sources for Use in Cognitive Adjudication
Minji Lee
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Summarizing PRO-CTCAE: A New Index from Averaged Composite Scores at a Cross-Sectional Timepoint
Summarizing PRO-CTCAE: A New Index from Averaged Composite Scores at a Cross-Sectional Timepoint
Nicola Mills
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Supporting Centres to Best Integrate an RCT and to Gain Confidence in it Can Optimise Informed Decision-Making and Recruitment to Surgical Trials: an Example from an Orthopaedic Surgical Trial
Supporting Centres to Best Integrate an RCT and to Gain Confidence in it Can Optimise Informed Decision-Making and Recruitment to Surgical Trials: an Example from an Orthopaedic Surgical Trial
Katie Gordon
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
The Benefits and Challenges of Incorporating an Integrated Process Evaluation: insights from the NIFTy trial
The Benefits and Challenges of Incorporating an Integrated Process Evaluation: insights from the NIFTy trial
Ajsi Kanapari
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
The effect of predicting Serious Adverse Event for guiding the enrollment procedure in Clinical Trials
The effect of predicting Serious Adverse Event for guiding the enrollment procedure in Clinical Trials
Jonathan Beall
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
The Highlights and Hiccups of High-Density Data
The Highlights and Hiccups of High-Density Data
Sherry Livingston
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
The Impact of Treatment Non-Adherence on Power and Sample Size in Clinical Trials
The Impact of Treatment Non-Adherence on Power and Sample Size in Clinical Trials
Lori Dodd
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
The modern clinical trial: managing threats to robust evidence
The modern clinical trial: managing threats to robust evidence
Lea Harvin
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
The PREVENTABLE Study Call Tracking and Schedule Management System
The PREVENTABLE Study Call Tracking and Schedule Management System
Selman Mirza
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
The Promise study: An international consensus process to develop guidance for assessing ‘promise of the intervention’ ahead of a randomized controlled trial
The Promise study: An international consensus process to develop guidance for assessing ‘promise of the intervention’ ahead of a randomized controlled trial
Annika Scheffold
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
The Randomization Working Group: Transforming Tomorrow’s Clinical Trials with Innovative Randomization Methodology
The Randomization Working Group: Transforming Tomorrow’s Clinical Trials with Innovative Randomization Methodology
Jessica Staloch
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
The Research eWorkflow Tool: A multi-user interactive screening process for clinical research workflow
The Research eWorkflow Tool: A multi-user interactive screening process for clinical research workflow
Cherish Boxall
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
The Role of Intersectionality in Shaping Participant Engagement with Digital Health Methods: Findings from a Qualitative Study
The Role of Intersectionality in Shaping Participant Engagement with Digital Health Methods: Findings from a Qualitative Study
Katherine Hull
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
The translation of interventional study findings for adults requiring maintenance dialysis into clinical guidelines
The translation of interventional study findings for adults requiring maintenance dialysis into clinical guidelines
Alice-Maria Toader
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
The use of healthcare systems data for RCTs
The use of healthcare systems data for RCTs
Rajenki Das
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Theory to Practice: Bayesian Response Adaptive Randomisation in a Rare Disease Setting
Theory to Practice: Bayesian Response Adaptive Randomisation in a Rare Disease Setting
Jacqueline Perez
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Too Many Cooks in the Kitchen? Lessons Learned from the Development of a Pragmatic Clinical Trial Protocol
Too Many Cooks in the Kitchen? Lessons Learned from the Development of a Pragmatic Clinical Trial Protocol
Lisa Yeager
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Transforming Clinical Trial Operations: A Journey to Enhance Collaboration and Resource Management Using the Atlassian Ecosystem
Transforming Clinical Trial Operations: A Journey to Enhance Collaboration and Resource Management Using the Atlassian Ecosystem
Fandi Chang
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Treatment effect estimation in the presence of cluster size dependent treatment heterogeneity in stepped wedge designs
Treatment effect estimation in the presence of cluster size dependent treatment heterogeneity in stepped wedge designs
Laura Gray
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Trials in Multiple long-term conditions (multimorbidity); asking the right questions and ensuring we have the right design and analysis to answer them.
Trials in Multiple long-term conditions (multimorbidity); asking the right questions and ensuring we have the right design and analysis to answer them.
Amanda Montgomery
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Twilio Alerts Within the PREVENTABLE Alert System
Twilio Alerts Within the PREVENTABLE Alert System
Sarah Heynemann
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Uncertainty and Novel Clinical Trial Designs in Oncology – When Should Equipoise Matter?
Uncertainty and Novel Clinical Trial Designs in Oncology – When Should Equipoise Matter?
Alexander Tam
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Understanding Recruitment Success in Canadian Trials: an Analysis of Trial Registry Data
Understanding Recruitment Success in Canadian Trials: an Analysis of Trial Registry Data
Jessie Barnett
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Understanding the Current Clinical Trials Landscape for Long COVID: An In-Depth Literature Review of Published Long COVID Clinical Trials Results Publications
Understanding the Current Clinical Trials Landscape for Long COVID: An In-Depth Literature Review of Published Long COVID Clinical Trials Results Publications
Arlene Ruiz
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Use of a Cloud-Based System for Central Review of De-Identified Echocardiograms in Clinical Trials
Use of a Cloud-Based System for Central Review of De-Identified Echocardiograms in Clinical Trials
Jennifer Gassman
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Use of varying-access database tables to manage Clinical Site and Study Personnel data for multi-center clinical trials
Use of varying-access database tables to manage Clinical Site and Study Personnel data for multi-center clinical trials
Elizabeth Rosenthal
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Using A Central Outcomes Center to Reduce Attrition in A Longitudinal ED-Based Pediatric Study
Using A Central Outcomes Center to Reduce Attrition in A Longitudinal ED-Based Pediatric Study
Nikki Totton
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Using Benefit-Risk Methods to Adjust the Non-Inferiority Margin Based On Treatment Benefits
Using Benefit-Risk Methods to Adjust the Non-Inferiority Margin Based On Treatment Benefits
Christina Yap
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Educational Session
Using patient-reported outcomes to understand treatment risks and benefits in clinical trials
Using patient-reported outcomes to understand treatment risks and benefits in clinical trials
Michael Mead
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Using PCORnet to Enhance Rare Disease Clinical Trial Research
Using PCORnet to Enhance Rare Disease Clinical Trial Research
Katie Gillies
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Using qualitative data to support the generation of robust answers for clinical trials
Using qualitative data to support the generation of robust answers for clinical trials
Aryelly Rodriguez
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Using re-identification risk scores on publicly available anonymised clinical trial datasets
Using re-identification risk scores on publicly available anonymised clinical trial datasets
Jennifer Talton
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Using REDCap to Facilitate Adjudication of Adverse Events
Using REDCap to Facilitate Adjudication of Adverse Events
Sean Hanlon
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
Using Technology to Ensure Clinical Trials Efficiently and Effectively Answer the Right Questions: The RECOVER-CT Experience
Using Technology to Ensure Clinical Trials Efficiently and Effectively Answer the Right Questions: The RECOVER-CT Experience
Katie Mariamne Loveday Hullock
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Utilising Routinely Collected Health Data (RCHD) to Enhance Long-Term Monitoring and Efficiency in Clinical Trials: Insights from 2 Academic Pragmatic Trials
Utilising Routinely Collected Health Data (RCHD) to Enhance Long-Term Monitoring and Efficiency in Clinical Trials: Insights from 2 Academic Pragmatic Trials
David Zahrieh
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Was it Worth It: A pooled analysis of participant experience in cancer chemoprevention trials
Was it Worth It: A pooled analysis of participant experience in cancer chemoprevention trials
Neža Dvoršak
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
When to Schedule the Interim Analysis in the Presence of Missing Data?
When to Schedule the Interim Analysis in the Presence of Missing Data?
Timo Tolppa
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Who are we missing from pragmatic critical care trials? Analysis of registry data from Nepal and Pakistan
Who are we missing from pragmatic critical care trials? Analysis of registry data from Nepal and Pakistan
Leila Rooshenas
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Why is de-implementation of ineffective interventions so difficult? Insights from clinical practitioners’ critiques of evidence and implications for trial design and planning.
Why is de-implementation of ineffective interventions so difficult? Insights from clinical practitioners’ critiques of evidence and implications for trial design and planning.
Marcos Sanches
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Contributed Session
Zero-Inflated Models: Loosing the Forest for the Trees? The Trade-off between Statistical Fit and Model Interpretation
Zero-Inflated Models: Loosing the Forest for the Trees? The Trade-off between Statistical Fit and Model Interpretation
Shera Weyers
2025 (Vancouver) Annual Meeting
2025 (Vancouver) Annual Meeting
Session Proposal
“The Future of Data Management in Resource-limited Settings: Asking the Right Questions and Optimizing Operations.”
“The Future of Data Management in Resource-limited Settings: Asking the Right Questions and Optimizing Operations.”